Navigation Links
Smokers may differ in their cravings for smoking

A brain scan study of the smokers reveals that the smokers may differ in their cravings// for a smoke depending on their brain’s sensitivity to smoking.

Researchers have found that the urge to smoke after a period of abstinence will vary in smokers according to the brain responses to the smoking habit. Researchers from the Duke University Medical Center had looked into the brain images of smokers in a bid to study the differential responses to quitting smoking.

Although nicotine cravings are considered to be at the root of not being able to quit smoking, recent research suggests that conditioned response to various sensory cues like presentation of visuals, or smelling of tobacco can also set the stage of continuous smoking for smokers who are not able to quit. In the new research scientists have found that those who can abstain from smoking for long hours, even after viewing smoking related visuals, showed more stable brain responses than the other smokers who felt the urge to smoke on seeing the same visuals.

The research suggests that people may differ in their tendencies to react to drugs, as their brain views the sensory cues differently. The researchers feel that this discovery may lead to differential use of quitting procedures for smokers depending on their brain responses.

Reference: Neuropsychopharmacology, online edition, June 2005
'"/>




Page: 1

Related medicine news :

1. Smokers children likely to develop caries
2. Smokers more prone to depression
3. Female Smokers More Prone To Lung Cancer
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women Smokers More Prone To Lung Cancer
6. Creating A Greater Awareness Among Smokers
7. Trained Counselors Counseling Pregnant Smokers To Quit May Not Work
8. Smokers Avoid Dental Care More Than Others
9. Smokers Face The Risk Of Becoming Blind In Later Life
10. New Vaccination For Smokers To Quit Smoking
11. B-Carotene Increases Oral Cancer Risk In Smokers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use his ... had a more child-friendly design, then children would be more likely to look forward ... avoid the need to deliver medication via a nebulizer mask. The design will not ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
(Date:12/8/2016)... ... 08, 2016 , ... With the increasing demand for dental implants, the National ... campaign to inform dentists and patients about the safety issues related to dental restorations. ... in the U.S. is projected to reach $6.4 billion in 2018 with more than ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Allergy Diagnostics Market: Scope and ... that are used to determine the presence of ... drugs etc. in the samples by determining the ... The report on global allergy diagnostics market, analyzes ... The report consists of an executive summary that ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
Breaking Medicine Technology: